Balanced news tone
News Sentiment
4534 sentiment intelligence
Mochida Pharmaceutical Co., Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-0.5% over one week, -2.0% over four weeks, trend inactive, and near fair-value range.
Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. – TSE:4534
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Enterprise value to EBITDA forward of Mochida Pharmaceutical Co., Ltd. – TSE:4534
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 23:42
- Source
- TradingView
Price to book forward of Mochida Pharmaceutical Co., Ltd. – TSE:4534
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 23:38
- Source
- TradingView
Mochida shares lean on business context as investors await new signals.
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 12:25
- Source
- ad-hoc-news.de
The CARP-III program from Mochida Pharmaceutical Co. - long-running B2B support for paediatric anaes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2026 23:11
- Source
- ad-hoc-news.de
Technical Analysis of Mochida Pharmaceutical Co., Ltd. (TSE:4534)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Feb 2018 23:10
- Source
- TradingView